JAMES GOLDEN: Open Payments
NPI 1154659688 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 8 payments from 6 companies in 2025. Trend: 2023 $202 · 2024 $156 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $51 |
| Stryker Corporation | 1 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: VERQUVO, ARTIX MT, AMVUTTRA, LEQVIO, JARDIANCE, ELIQUIS.
Industry payments across TX — which companies pay providers there.
